Chapter 11: Antifungal Agents

Antifungal Agents pharmacology chapter details the classification, mechanisms, and safe administration of antifungal agents, drugs crucial for treating infections known as mycoses. Fungi are distinct cellular organisms characterized by a rigid cell wall made of chitin and polysaccharides, and a cell membrane stabilized by ergosterol. This unique structure provides resistance to standard antibiotics. The rise in immunocompromised populations, including those with AIDS or those undergoing transplantation, has increased the prevalence of systemic and localized fungal infections, such as Candida (yeast infections, thrush) and tinea (ringworm, athlete's foot). Systemic antifungals are potent medications reserved for serious, often life-threatening mycoses, functioning primarily by altering fungal cell permeability to inhibit replication (fungistatic) or induce cell death (fungicidal). Major systemic classes include the Azole Antifungals (e.g., fluconazole, ketoconazole), which block sterol activity and are notable for causing severe hepatic toxicity and numerous drug-drug interactions due to strong inhibition of the CYP450 enzyme system. Another class, the Echinocandins (e.g., caspofungin, micafungin), works by specifically inhibiting glucan synthesis necessary for the fungal cell wall. Other high-alert systemic agents include amphotericin B, which is reserved for progressive, potentially fatal infections due to its significant risk of nephrotoxicity and bone marrow suppression. Nursing considerations for all systemic agents mandate thorough assessment of patient history for existing hepatic or renal impairment, obtaining cultures to identify the pathogen, and rigorously monitoring renal and hepatic function throughout the prolonged treatment course. Topical Antifungals are used exclusively for localized infections of the skin and mucous membranes, such as those caused by dermatophytes. Since topical agents (e.g., clotrimazole, nystatin) are generally not absorbed systemically, caution is required to prevent their use near open wounds or draining areas, which could increase absorption and toxicity risk. Patient education is paramount, emphasizing completing the full drug course, managing potential adverse effects like GI upset and CNS changes, and immediately reporting warning signs of severe organ toxicity, such as yellowing of the skin or severe nausea and vomiting.